US Stock Futures and Bond Yields Decline on Reports of Putins Updated Nuclear Doctrine Wall Street Ends Higher as Healthcare Technology Lead Communication Services Lags Baird Raises Price Target on RideNow Group Following Strong SameStore Sales Performance Wall Street Futures Edge Higher as USIran Talks and AI Rebound Fuel Optimism Spiking SP 500 Profits Why DoubleDigit Earnings Growth May Signal a Market Peak UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Activities to Ease Cost of Living Pressures AMTB Q1 2026 Earnings EPS Slightly Below Estimates Shares Edge Higher CNO Q1 2026 Earnings Strong Earnings Beat Amid Modest Stock Decline Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates but Stock Posts Modest Gain GBFH Q1 2026 Earnings EPS Falls Sharply Below Estimates Stock Retreats SKM Q4 2025 Earnings EPS Misses Estimates Stock Declines Neonode Q1 2026 Earnings EPS Misses Estimates Amid Limited Revenue Disclosure Arrive AI Inc ARAI Rises 13 Nears Key Resistance at 067 Definium Therapeutics DFTX Slides Slightly Approaches Key Support Level WilliamsSonoma WSM Holds Steady Near Resistance Key Levels to Watch Tenon Medical Inc TNON Holds Steady Near 072 Support Level A Mild Uptick Amid Narrow Trading Range The Honest Company HNST Edges Higher as Stock Tests Key Resistance Near 385 PDD Holdings Stock Declines as Temu Parents Quarterly Revenue Falls Short of Market Expectations Green Plains GPRE Q1 2026 Earnings Massive EPS Beat of 63555 Drives Stock Higher Talon Capital Corp Warrants TLNCW Hold Steady at 050 as Traders Await Catalyst PFE Q1 2026 Earnings EPS Beats Estimates Amid Revenue Disclosure Gap Roku Q1 2026 Earnings Strong Profit Beat Signals Operating Discipline VRCA Q1 2026 Earnings EPS Misses Estimates as Company Advances Pipeline GEF Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Outlook Permian Resources Corporation PR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Challenges TXO Partners LP Q1 2026 Earnings Deep Loss Per Unit Fails to Deter Investors Stock Gains 393 DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus